FDA Considers New HPV Vaccine Cervarix

fda.gov — “The FDA today approved Cervarix, a new vaccine to prevent cervical cancer and precancerous lesions caused by human papillomavirus (HPV) types 16 and 18. The vaccine is approved for use in girls and women ages 10 years through 25 years.” View full resource at fda.gov

Most Recently Shared on October 19, 2009 at 4:49 pm By:

Gannett Healthcare Health News

FDA Approves Cervarix Vaccine for Prevention of Cervical Cancer: http://bit.ly/3aQ67b

3 years ago...

Retweet

Favorite

FDA advisory panel agrees Cervarix effective to prevent HPV

pediatricsupersite.com — “An FDA advisory panel agreed today that GlaxoSmithKline’s human papillomavirus vaccine, Cervarix, was effective at preventing the two HPV type” View full resource at pediatricsupersite.com

Most Recently Shared on September 9, 2009 at 7:30 pm By:

Pediatric SuperSite Health Site

FDA advisory panel agrees Cervarix effective to prevent #HPV, considering male vaccination with Gardasil: http://ow.ly/oI8U

3 years ago...

Retweet

Favorite

FDA committee to consider Gardasil alternative for HPV | Booster Shots | Los Angeles Times

latimesblogs.latimes.com — “A Food and Drug Administration advisory committee will meet Wednesday in Washington to consider possible approval of Cervarix, a vaccine against human papilloma virus (HPV) manufactured by GlaxoSmithKline Biologicals. The vaccine is designed to protect against two strains of HPV...” View full resource at latimesblogs.latimes.com